A tale of two cohorts: Are we overestimating the risk of colorectal cancer in inflammatory bowel disease?

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 288-290

  Nguyen, Geoffrey C ^a   Bressler, Brian ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE DURATION; FAMILY HISTORY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; META ANALYSIS (TOPIC); PANCOLITIS; PHENOTYPE; PRECANCER; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 84864230890     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.06.027     Document Type: Editorial

References (13)

1. J.A. Eaden, K.R. Abrams, J.F. Mayberry The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526 535 (Pubitemid 32234798)
2. C. Canavan, K.R. Abrams, J. Mayberry Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease Aliment Pharmacol Ther 23 2006 1097 1104 (Pubitemid 43779348)
3. F.A. Farraye, R.D. Odze, J. Eaden AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 746 774
4. S.H. Itzkowitz, D.H. Present Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease Inflamm Bowel Dis 11 2005 314 321 (Pubitemid 40439686)
5. F.A. Farraye, R.D. Odze, J. Eaden AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 738 745
6. P.D. Collins, C. Mpofu, A.J. Watson Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease Cochrane Database Syst Rev 2006 CD000279
7. F.S. Velayos, J.P. Terdiman, J.M. Walsh Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies Am J Gastroenterol 100 2005 1345 1353 (Pubitemid 40904360)
8. Nguyen GC, Gulamhusein A, Bernstein CN. Aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations. Am J Gastroenterol. Forthcoming.
9. T. Jess, J. Simonsen, K.T. Jorgensen Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years Gastroenterology 143 2012 375 381
10. T. Jess, L. Riis, I. Vind Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark Inflamm Bowel Dis 13 2007 481 489 (Pubitemid 46668255)
11. D. Provenzale, K.V. Kowdley, S. Arora Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis Gastroenterology 109 1995 1188 1196
12. D. Provenzale, J.B. Wong, J.E. Onken Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis Am J Gastroenterol 93 1998 872 880 (Pubitemid 29076969)
13. L.J. Herrinton, L. Liu, T.R. Levin Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010 Gastroenterology 143 2012 382 389